Recursion Pharmaceuticals (NASDAQ:RXRX) reported quarterly losses of $(0.31) per share. This is a 18.42 percent increase over losses of $(0.38) per share from the same period last year. The company reported $13.68 million in sales this quarter. This is a 439.91 percent increase over sales of $2.53 million the same period last year.
TV Networks, Desperate For Live Sports, Just Showered The Big Ten Colleges With Nearly $8 Billion
The Big Ten forged a new seven-year contract with Fox Corp (NASDAQ: FOX), Paramount Global (NASDAQ: PARA) CBS, and Comcast Corp (NASDAQ:
